Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/. Initial shipment of THC extracts into the European Union.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

AUGUST 5, 2021

NEO:FH , Forum ), an exclusively natural psychedelic drug development company. To support its mission, the company has a robust portfolio of extraction and purification methods, a botanical extraction management team, a Health Canada psilocybin Dealer’s License, and in-house GMP manufacturing capabilities. Investment summary.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

MAY 26, 2022

Australia’s Commonwealth Scientific and Industrial Research Organisation has been issued a licence to conduct research into psychedelic drug treatments. In an announcement on 18 May, CSIRO said it was moving into the research area to investigate the use of psychedelic drugs in treating mental illness. Read more subscribers only.

Research and Development 52

Research and Development Extraction Treatment Medicine 52

Cannabis Law Report

JUNE 7, 2021

(CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that it has received its Cannabis Research Licence under Health Canada’s Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Voyage Cannabis Corp.

Research and Development 95

Research and Development Extraction Recreational Topical 95

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Strains 105

Cannabis Law Report

AUGUST 17, 2022

THE UK Government through its innovation agency is set to provide almost £500,000 of funding to an English company to develop proprietary cannabidiol synthesis technology. The cash from Innovate UK has been earmarked for County Durham company Canna Group and will be used to develop bespoke technology to manufacture CBD-HQ.

Research and Development 52

Research and Development Topical Extraction CBD 52

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

OCTOBER 26, 2021

Delic Holding Corp Inc. (“ DELIC ” or the “ Company “) (CSE: DELC) (OTCQB: DELCF ) (FRA: 6X0) ( Original Source ), a leader in new medicines and treatments for a modern world, today announced that its subsidiary, Delic Labs , has entered into a co-marketing partnership with GT Research Inc. (“GTR”)

Research and Development 52

Research and Development Extraction Medicine Treatment 52

Cannabis Law Report

NOVEMBER 23, 2021

(OTC PINK:CBGL), an innovation-oriented company investing in disruptive cannabis technologies, today announces an important enhancement to its cannabis product manufacturing capabilities at its Natural Plant Extract of California facility in Lynwood, a suburb of Los Angeles.

Extraction 52

Extraction Research and Development Concentrates Edibles 52

MMJ Recs

APRIL 30, 2024

In the United States, medical marijuana cultivation is governed by a patchwork of state laws and regulations. Marijuana Processing Techniques Once the cannabis plants reach maturity, they undergo processing to extract the beneficial compounds, such as cannabinoids and terpenes.

Cultivation 52

Cultivation Supply Chain Extraction Marijuana 52

Cannabis Law Report

JANUARY 10, 2022

Panacea”), a leading United States biotechnology company focused on developing new therapeutic, cultivation, extraction and isolation techniques for high value natural products such as psychedelic-containing lifeforms and cannabis. is a Canadian biotechnology company providing cannabis testing and research services.

Research and Development 52

Research and Development Supply Chain DEA Events 52

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

OCTOBER 4, 2021

A major component of the program will be the development of new ways to infuse both the psychedelic compounds and fungi components into products to both improve bioavailability and to mask the bitter tastes of the fungus and its components. ” About Provisional Patent Filings.

Food 52

Food Programs Research and Development Collective 52

Cannabis Law Report

JUNE 21, 2021

But, as more and more researchers are suggesting the use of marijuana for medical conditions, the restriction might be less strict in the future. Japan permits their citizen to consume CBD products extracted from hemp seed. Therefore, you have to wait longer for the cannabis law to become lenient in this country.

Law 103

Law Seed-To-Sale Research and Development Consumption 103

Cannabis Law Report

AUGUST 19, 2021

Agreement allowing work on numerous collaborative research initiatives in the coming years. The Johns Hopkins Behavioral Pharmacology Research Unit has extensive experience conducting clinical research related to therapeutic use of psychedelics. DENVER, Aug. Johnson, Ph. About Mydecine Innovations Group.

Medicine 98

Medicine Research and Development Therapy Pharmaceutical 98

Cannabis Law Report

OCTOBER 20, 2021

11,110,372, covering a method of extracting and isolating compounds from the plants of the Cannabis genus at low temperature using cold organic solvents. Leveraging this patent, the Company plans to pursue licensing opportunities for its unique extraction process with manufacturers. About Neptune Wellness Solutions Inc.

Extraction 52

Extraction Supply Chain Research and Development Retail 52

Cannabis Law Report

OCTOBER 6, 2021

The lab currently holds a 56 Research Exemption for chemistry analytics on psilocybin mushrooms. Additionally, the lab has applied for a Dealer’s License and intends to eventually commercialize its psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Extraction Treatment Safety 52

Canna Law Blog

JULY 24, 2020

On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018. tablet or capsule).

CBD 92

CBD Research and Development DEA Concentrates 92

Cannabis Law Report

DECEMBER 15, 2021

Benjamin Manufacturing Company to provide cultivation and processing facilities for psilocybin-containing mushrooms for authorized research purposes. market for research purposes is absolutely key for us as we look to expand our business in 2022,” he adds. VANCOUVER, BC , Dec. 13, 2021 /CNW/ – Havn Life Sciences Inc.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Veriheal

FEBRUARY 19, 2021

The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. . Residue Solvents.

Legalization 87

Legalization Research and Development Safety Data 87

Cannabis Law Report

JULY 2, 2021

Cannabis magazine reports on the landlocked Pyrenees state developing its own medical cannabis industry. IRTA and Andorra Research and Innovation will define a model for the cultivation and industrial transformation of this plant in the country.

Research and Development 52

Research and Development Cultivation Extraction Medicine 52

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. The platform technology has been successfully utilized with both water soluble and insoluble compounds and extracts.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Life Network

FEBRUARY 24, 2023

The study, which analyzed data from 175,000 people, said cannabis consumers are 34% more likely to develop the heart condition. The researchers claim tetrahydrocannabinol (THC) interacts with the body’s blood vessels promoting inflammation and plaque buildup.

Research and Development 97

Research and Development Vaping Data Edibles 97

Cannabis Law Report

APRIL 17, 2022

billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com. The two major cannabinoids extracted from this plant that provide medical benefits include tetrahydrocannabinol (THC) and cannabidiol (CBD). billion euros ($1.67 Medical cannabis to be sold in pharmacies.

Research and Development 52

Research and Development Chronic Pain Recreational Environment 52

Cannabis Law Report

OCTOBER 16, 2022

Mugglehead reports The company believes it now owns the largest cannabis R&D cultivation site on the globe Eden Pharma Ltd claims to have acquired the largest cannabis development site in the world.

Extraction 52

Extraction Cultivation Cannabis 52

Cannabis Law Report

SEPTEMBER 3, 2019

Thailand has removed cannabis and hemp extracts from its narcotics list, officials said on Monday, the latest effort to promote the development of marijuana products for medical purposes. “We are working towards cannabidiol (CBD) extraction, that’s our short term goal,” Shah told Reuters.

Extraction 45

Extraction Hemp Research and Development Media 45

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

AUGUST 26, 2019

ASX-listed MGC Pharmaceuticals has partnered with the Slovenian Institute of Hop Research and Brewing, or “IHPS”, to carry out a ground-breaking, large-scale research project on the use of cannabis for medical purposes. Read the full story at [link].

Research and Development 45

Research and Development Pharmaceutical Extraction Cultivation 45

Cannabis Law Report

JUNE 21, 2021

Dr. Dadi Segal , Founder and CEO of Panaxia Israel : “We are excited to be the first and exclusive company in Europe to receive a marketing permit for inhaled medical cannabis extracts.

Extraction 59

Extraction Pharmaceutical Research and Development Patients 59

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960).

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

DECEMBER 11, 2021

Curaleaf International is the leading vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. Counsel, Labor & Employment Law- IL based or Remote.

Law 52

Law Research and Development Environment Compliance 52

The Blunt Truth

MARCH 6, 2023

With the increased funding pouring into this sector has come a desire to protect the intellectual property in the products, research, and developments brought to market. The illegality doctrine, as it sounds, is the premise that a plaintiff can’t use a court of law to safeguard illegal activity. 2:21-cv-08756-JWH-SHK, ECF No.

Extraction 98

Extraction Banking Research and Development Topical 98